220
Views
35
CrossRef citations to date
0
Altmetric
Original Research

Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor

ORCID Icon, ORCID Icon, ORCID Icon, , , ORCID Icon, , , , , , ORCID Icon, , , ORCID Icon & show all
Pages 661-669 | Published online: 17 Feb 2021

References

  • WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020 [Internet]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020. Accessed Jun 19, 2020
  • Pei X, Jiao X, Lu D, Qi D, Huang S. How to face COVID-19 in ophthalmology practice medical hypothesis, discovery & innovation in ophthalmology. Available from: http://mehdijournal.com/index.php/mehdiophthalmol/article/view/830. Accessed January 29, 2021.
  • Hu VH, Watts E, Burton M, et al. Protecting yourself and your patients from COVID-19 in eye care. Community Eye Health. 2020;33(108):S1–6.
  • Tognetto D, Brézin AP, Cummings AB, et al. Rethinking elective cataract surgery diagnostics, assessments, and tools after the COVID-19 pandemic experience and beyond: insights from the EUROCOVCAT GROUP. DIAGNOSTICS (Basel). Diagnostics. 2020;10(12):E1035. doi:10.3390/diagnostics10121035
  • Ferrara M, Romano V, Steel DH, et al. Reshaping ophthalmology training after COVID-19 pandemic. Eye. 2020;1:1–9.
  • Jørstad ØK, Steffensen LA, Eriksen K, Bragadóttir R, Moe MC. Thirteen years of intravitreal anti-vascular endothelial growth factor therapy: the promises and burdens of a paradigm shift told from the perspective of the largest retina service in Norway. Acta Ophthalmol. 2020;98(8):774–779.
  • Plyukhova AA, Budzinskaya MV, Starostin KM, et al. Comparative Safety of Bevacizumab, Ranibizumab, and Aflibercept for Treatment of Neovascular Age-Related Macular Degeneration (AMD): A Systematic Review and Network Meta-Analysis of Direct Comparative Studies. J Clin Med. 2020;189(5):1522. doi:10.3390/jcm9051522
  • Reibaldi M, Russo A, Avitabile T, et al. Treatment of persistent serous retinal detachment in Vogt-Koyanagi-Harada syndrome with intravitreal bevacizumab during the systemic steroid treatment. Retina. 2014;34(3):490–6. doi:10.1097/IAE.0b013e3182a0e446
  • Yousef YA, ElRimawi AH, Nazzal RM, et al. Coats' disease: characteristics, management, outcome, and scleral external drainage with anterior chamber maintainer for stage 3b disease. Medicine (Baltimore). 2020;99(16):e19623. doi:10.1097/MD.0000000000019623
  • Recommendations for urgent and nonurgent patient care [Internet]. Available from: https://www.aao.org/headline/new-recommendations-urgent-nonurgent-patient-care. Accessed Jun 19, 2020
  • American Society of Retina Specialists (ASRS) member alert regarding the COVID-19 pandemic [Internet]. Available from: https://www.asrs.org/practice/asrs-member-alert-regarding-covid-19-pandemic. Accessed Jun 19, 2020.
  • Al-Tammemi AB. The battle against COVID-19 in Jordan: an early overview of the Jordanian experience. Front Public Health. 2020;8.
  • COVID-19 community mobility report: Jordan. [Internet]. Google; [ cited Jun 19, 2020]. Available from: https://www.gstatic.com/covid19/mobility/2020-04-11_JO_Mobility_Report_en.pdf. Accessed January 29, 2021.
  • Kramer JB, Brown DE, Kopar PK. Ethics in the time of coronavirus: recommendations in the COVID-19 Pandemic. J Am Coll Surg. 2020;230(6):1114–1118. doi:10.1016/j.jamcollsurg.2020.04.004
  • Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M. Visual acuities “hand motion” and “counting fingers” can be quantified with the Freiburg visual acuity test. Invest Ophthalmol Vis Sci. 2006;47(3):1236–1240. doi:10.1167/iovs.05-0981
  • Antaki F, Dirani A. Treating neovascular age-related macular degeneration in the era of COVID-19. Graefes Arch Clin Exp Ophthalmol. 2020;1–3.
  • Corradetti G, Corvi F, Nguyen TV, Sadda SR Management of neovascular age-related macular degeneration during the COVID-19 pandemia. Ophthalmol Retina. doi: 10.1016/j.oret.2020.05.015
  • Colantuono D, Miere A, Semoun O, Amoroso F, Souied EH. AMD management during the COVID‐19 Pandemic. Acta Ophthalmol. 2020;98. doi:10.1111/aos.14469
  • Shmueli O, Chowers I, Levy J. Current safety preferences for intravitreal injection during COVID-19 pandemic. Eye. 2020;34(7):1165–1167. doi:10.1038/s41433-020-0925-x
  • Romano F, Monteduro D, Airaldi M, et al. Increased number of submacular hemorrhages as a consequence of coronavirus disease 2019 lockdown. Ophthalmol Retina. 2020;4(12):1209–1210. doi:10.1016/j.oret.2020.06.027
  • Ghanbari V, Ardalan A, Zareiyan A, Nejati A, Hanfling D, Bagheri A. Ethical prioritization of patients during disaster triage: a systematic review of current evidence. Int Emerg Nurs. 2019;1(43):126–132.
  • Toro MD, Brézin AP, Burdon M, et al. Early impact of COVID-19 outbreak on eye care: insights from EUROCOVCAT group. Eur J Ophthalmol. 2020;31:1120672120960339. doi:10.1177/1120672120960339
  • Toro M, Choragiewicz T, Posarelli C, Figus M, Rejdak R. European COVID-19 cataract group (#EUROCOVCAT).Early impact of COVID-19 outbreak on the availability of cornea donors: warnings and recommendations. Clin Ophthalmol. 2020;14:2879–2882. doi:10.2147/OPTH.S260960
  • Wu S, Zheng D, Liu Y, Hu D, Wei W, Han G Radiation therapy care during a major outbreak of COVID-19 in Wuhan. Adv Radiat Oncol. 2020. [ cited 2020]; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270882/.
  • Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17(5):268–270. doi:10.1038/s41571-020-0362-6
  • Thomas DS, Warwick A, Olvera-Barrios A, et al. Estimating excess visual loss in people with neovascular age-related macular degeneration during the COVID-19 pandemic. medRxiv. 2020.
  • Schmidt-Erfurth U, Eldem B, Guymer R, et al. Efficacy and safety of monthly versus quarterly ranibizumab treatment in neovascular age-related macular degeneration: the EXCITE study. Ophthalmology. 2011;118(5):831–839. doi:10.1016/j.ophtha.2010.09.004
  • Boyd MJ, Scott DAR, Squirrell DM, Wilson GA. How urgent do intravitreal anti-VEGF injections need to be to justify the risk of transmitting COVID-19? Proof-of-concept calculations to determine the Health Adjusted Life-Year (HALY) trade-off. medRxiv. 2020;4.
  • Heier JS, Campochiaro PA, Yau L, et al. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON Trial. Ophthalmology. 2012;119(4):802–809.
  • Lee R, Wong TY, Sabanayagam C. Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis
  • Apte RS. What is chronic or persistent diabetic macular edema and how should it be treated? JAMA Ophthalmol. 2016;134(3):285–286. doi:10.1001/jamaophthalmol.2015.5469
  • Beauchamp TL, Childress JF. Principles of Biomedical Ethics. Aufl New York: Oxford; 2013:7.
  • Ebbesen M, Pedersen BD. Empirical investigation of the ethical reasoning of physicians and molecular biologists – the importance of the four principles of biomedical ethics. Philos Ethics Humanit Med. 2007;2(1):23. doi:10.1186/1747-5341-2-23
  • Al-Tabba’ A, Al-Hussaini M, Mansour R, Sultan H, Abdel-Razeq H, Mansour A. Ethical considerations for treating cancer patients during the SARS-CoV-2 virus crisis: to treat or not to treat? A literature review and perspective from a cancer center in low-middle income country. Front Med
  • Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl1):S27–36. doi:10.4103/2230-8210.94253
  • AlRyalat SA, Abukahel A, Elubous KA. Randomized controlled trials in ophthalmology: a bibliometric study. F1000Research. 2019;4(8):1718. doi:10.12688/f1000research.20673.1